INTRODUCTION
============

Dysphagia after prolonged orotracheal intubation (OTI)-longer than 48 h^(^ [@B01] ^-^ [@B03] ^)^-is defined as the inability to effectively transfer food from the mouth into the stomach. ^(^ [@B04] ^)^ This type of dysphagia has an incidence of 44% to 87%^(^ [@B03] ^,^ [@B05] ^,^ [@B06] ^)^ of cases after extubation, and it can increase morbidity and mortality.^(^ [@B07] ^)^ According to data collected from hospitals in the USA, the annual cost of patients with dysphagia exceeds US\$500 million.^(^ [@B04] ^)^

Recently, one of the concerns has been the study of dysphasia and its impact on the health care system.^(^ [@B08] ^-^ [@B11] ^)^ Dysphagia after prolonged OTI delays the resumption of oral feeding, increases the risk for lung diseases, and delays hospital discharge.^(^ [@B12] ^,^ [@B13] ^)^ In this scenario, early identification of predictors of aspiration is extremely relevant for priority treatment of at-risk patients, with the institution of appropriate measures and promotion of safe and speedy resumption of oral feeding.^(^ [@B14] ^)^ There are several tests available for the diagnosis of dysphagia after prolonged OTI, including bedside swallowing assessment, performed by a speech-language pathologist, as well as imaging (videofluoroscopy and videoendoscopy).^(^ [@B15] ^)^ However, it is of note that the use of such tests is not a reality in most treatment centers, in addition to the fact that indications for their use in critically ill patients are limited.^(^ [@B10] ^)^

A recent study^(^ [@B15] ^)^ investigated clinical predictors of dysphagia after prolonged OTI, on the basis of the results of clinical bedside swallowing assessments. The authors concluded that patients presenting with food or liquid escaping from the mouth or nose, multiple swallows, abnormal cervical auscultation findings, choking, altered voice quality, and cough after swallowing should be promptly evaluated before resumption of oral feeding. Other studies using bedside assessments have reported that the following signs are indicative of risk of aspiration: voice quality after swallowing^(^ [@B16] ^,^ [@B17] ^)^ and cough after swallowing.^(^ [@B17] ^,^ [@B18] ^)^

It is known that dysphagia severity after prolonged OTI is related to However, there are studies that have assessed the association of dysphagia with other risk factors, such as measures of patient severity of illness. ^(19\ 21)^ In such studies, the authors included the results of instruments that determine patient severity of illness at the time of admission, such as the Sequential Organ Failure Assessment (SOFA) and the Acute Physiology and Chronic Health Evaluation II (APACHE II).^(^ [@B19] ^-^ [@B21] ^)^

Two current studies used SOFA scores calculated at ICU admission for investigating their correlations with dysphagia severity.^(^ [@B19] ^,^ [@B20] ^)^ Both studies found that patient severity of illness at the time of admission was not associated with dysphagia severity (determined by bedside assessment). Patients with mild dysphagia or normal swallowing had SOFA scores similar to those of patients with severe dysphagia.

Another study,^(^ [@B21] ^)^ the objective of which was to investigate the demographic and clinical factors associated with dysphagia after prolonged OTI in patients with pulmonary changes, analyzed the results of scales that measure severity of illness (SOFA and APACHE II scores) as possible factors related to post-extubation dysphagia severity. Results of the regression analysis showed that four variables were significant: duration of intubation; upper gastrointestinal comorbidity; SOFA score; and low BMI.

Therefore, the objective of the present study was to determine whether the severity of non-neurological critically ill patients correlates with clinical predictors of bronchial aspiration (bedside swallowing assessment).

METHODS
=======

We conducted a prospective, observational, cross-sectional study, which was approved by the local research ethics committee (Code No. CAPPesq 311784). The data collection procedures began only after obtaining written informed consent from the patients or their legal guardians.

The study participants were patients who underwent bedside swallowing assessment, by physician request, and were being treated in the Department of Speech Therapy of the University of São Paulo School of Medicine *Hospital das Clínicas* Central Institute, located in the city of São Paulo, Brazil, between January of 2013 and January of 2015.

The inclusion criteria were having undergone prolonged OTI (\> 48 h)^(^ [@B01] ^-^ [@B03] ^)^; being \> 18 years of age; not having or having had a tracheostomy; not having neurological or neurodegenerative disorders; not having a history of esophageal dysphagia; not having lung or neck cancer or having undergone surgical procedures in those regions; and having undergone bedside swallowing assessment within the first 48 h after extubation.

The steps in the data collection process of this study are described below.

Clinical speech pathology assessment of the risk of bronchial aspiration
------------------------------------------------------------------------

The risk of bronchial aspiration was determined on the basis of the Dysphagia Risk Evaluation Protocol (DREP).^(^ [@B10] ^,^ [@B15] ^)^ The DREP is intended for early bedside assessment of the patient\'s risk of dysphagia. This protocol involves the controlled administration of water and puree volumes. The final result of the DREP determines whether the patient can receive larger volumes and different textures of foods and liquids, as well as indicating whether monitoring is required for safe feeding. The results observed for each protocol item are recorded as either \"pass\" or \"fail\".

A recently published study investigated predictors of dysphagia after prolonged OTI,^(^ [@B15] ^)^ on the basis of the DREP results for a 5-mL water swallow test. In that study, the authors concluded that the predictors of dysphagia in the study population were food or liquid escaping from the mouth or nose, multiple swallows, abnormal cervical auscultation findings, voice quality after swallowing, cough after swallowing, and choking. Therefore, those DREP items were considered in the analysis and were assessed for correlations with the other data in the study.

Level of swallowing function
----------------------------

Level of swallowing function was determined with the use of the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS) scale.^(^ [@B22] ^)^ This scale is a multidimensional tool that assesses the degree of feeding supervision required by and the food/liquid textures that are safe for each patient, producing a single number between 1 and 7. For the purposes of the present study, the ASHA NOMS scale scores were determined after full completion of the DREP and, when necessary, after clinical swallowing assessment. Therefore, level of swallowing function was classified as follows: level 1: the individual is not able to swallow anything safely by mouth, and all nutrition and hydration are received through non-oral means; level 2: the individual is not able to swallow safely by mouth for nutrition and hydration, but may take some consistency, in therapy only, with consistent maximal cues, and an alternative method of feeding is required; level 3: an alternative method of feeding is required as the individual takes less than 50% of nutrition and hydration by mouth, and/or swallowing is safe with use of moderate cues to use compensatory strategies, and/or the individual requires maximum diet restriction; level 4: swallowing is safe, but usually requires moderate cues to use compensatory strategies, and/or the individual has moderate diet restrictions and/or still requires an alternative method of feeding and/or oral supplements; level 5: swallowing is safe with minimal diet restriction and/or occasionally requires minimal cues to use compensatory strategies, the individual may occasionally self-cue, and all nutrition and hydration needs are met by mouth at mealtime; level 6: swallowing is safe, and the individual eats and drinks independently, rarely requires minimal cues to use compensatory strategies, usually self-cues when difficulty occurs, but may need to avoid specific food items (e.g., popcorn and peanuts) and/or require additional time (because of dysphagia); and level 7: the individual\'s ability to eat independently is not limited by swallow function, which is safe and efficient for all consistencies, and compensatory strategies are effectively used when needed.

Patient severity of illness
---------------------------

Patient severity of illness at the time of clinical speech pathology assessment was determined by using the SOFA score,^(^ [@B23] ^)^ recorded on the medical chart on the basis of clinical and laboratory test results. This score is a tool that is used on a daily basis in critically ill patients during their ICU stay, to determine the degree of organ dysfunction/failure quantitatively and objectively. The SOFA score is used not to determine patient outcome, but rather to describe complications in critically ill patients. The two major objectives of SOFA are to improve the understanding of organ dysfunction and how impairments in several organs are related to each other and to assess the effects of medical treatment.

To determine patient severity of illness, scores ranging from zero (normal) to four (highest degree of impairment) are assigned to the various organ systems (respiratory, cardiovascular, hematological, hepatic, central nervous system, and renal). Each organ system receives a separate score, and the final score is obtained by summing all scores. The maximum score is 20, which is indicative of the highest degree of severity. The criteria for assigning points are described in [Chart 1](#t06){ref-type="table"}.

Chart 1.Sequential Organ Failure Assessment scoring system.**VariableScore01234Respiratory system**PaO~2~/FiO~2~, mmHg\> 400≤ 400≤ 300≤ 200^a^≤ 100^a^**Hematological system**Platelets, ×10^3^/mm^3^\> 150≤ 150≤ 100≤ 50≤ 20**Hepatic system**Bilirubin, mg/dL (µmol/L)\< 1.2 (\< 20)1.2-1.9 (20-32)2.0-5.9 (33-101)6.0-11.9 (102-204)\> 12.0 (\> 204)**Cardiovascular system**HypotensionNo hypotensionMAP \< 70 mmHgDopamine ≤ 5 or dobutamine at any dose^b^Dopamine \> 5, epinephrine ≤ 1, or norepinephrine ≤ 0.1^b^Dopamine \> 15, epinephrine \> 0.1, or norepinephrine \> 0.1^b^**CNS**Glasgow Coma Scale1513-1410-126-9\< 6**Renal system**Creatinine, mg/dL (µmol/L)\< 1.2 (\< 110)1.2-1.9 (110-170)2.0-3.4 (171-299)3.5-4.9 (300-440)\> 5.0 (\> 440)Urine output, mL/dayN/AN/AN/A\< 500\< 200[^1]

Data analysis
-------------

Assumptions of normality of distribution in each group and homogeneity of variances among the groups were tested using the Shapiro-Wilk test and Levene\'s test, respectively.

To compare SOFA scores among the different levels of swallowing function, we used the Kruskal-Wallis test, and, when multiple comparisons were necessary, we used Dunn\'s test. Categorical variables were analyzed with the chi-square test and Fisher\'s exact test. The level of statistical significance was set at 5% (p ≤ 0.05) for all analyses.

RESULTS
=======

After the inclusion criteria were applied, the final study sample consisted of 150 patients. The underlying diagnoses of the patients included in the study were as follows: lung disease, in 59 patients; multiple trauma without traumatic brain injury, in 18; kidney and liver transplants, in 12; heart disease, in 11; vascular disease, in 11; liver disease, in 10; kidney disease, in 10; infectious disease, in 6; gastroenterological disease, in 5; rheumatic disease, in 5; and endocrine disease, in 3.

The distribution of the patients by level of swallowing function, as determined by the ASHA NOMS scale after bedside speech pathology assessment, was as follows: 3 patients at level 1; 35 at level 2; 22 at level 3; 27 at level 4; 12 at level 5; 10 at level 6; and 41 at level 7. For the purposes of statistical analysis, the patients were grouped as follows: those at levels 1 and 2, ASHA1; those at levels 3 to 5, ASHA2; and those at levels 6 and 7, ASHA3. The group comparison by age and duration of intubation is shown in [Table 1](#t01){ref-type="table"}.

Table 1.Age and duration of intubation in the patients studied.**VariableGroupp\*ASHA1ASHA2ASHA3**Age, years62.00 ± 17.4055.30 ± 17.4846.40 ± 18.30\< 0.001Duration of intubation, days7.60 ± 3.976.20 ± 3.384.90 ± 2.70\< 0.001[^2]

Statistical analysis using the Kruskal-Wallis test showed significant differences in age between the ASHA1 and ASHA3 groups (p \< 0.001) and between the ASHA2 and ASHA3 groups (p = 0.026), patients in the ASHA3 group being younger than those in the other two groups. Mean duration of intubation (in days) was shortest in the ASHA3 group, and there was a significant difference between that group and the ASHA1 group (p = 0.001).

[Table 2](#t02){ref-type="table"} shows the comparison of predictors of bronchial aspiration among different levels of swallowing function.

Table 2.Comparison of predictors of bronchial aspiration among levels of swallowing function.**Clinical signResultGroupp\*ASHA1ASHA2ASHA3(n = 38)(n = 61)(n = 51)**Extraoral loss^a^Pass3557500.402Fail341Multiple swallowsPass2442440.030Fail14197Abnormal cervical auscultation findingsPass215251\< 0.001Fail1790Wet voicePass3155510.009Fail760CoughPass163750\< 0.001Fail22241ChokingPass3152510.008Fail790[^3]

The results indicated that the predictor \"food or liquid escaping from the mouth or nose\" did not differentiate among the swallowing function level groups. The predictors \"abnormal cervical auscultation findings\" and \"cough\" after swallowing were the indicators that best differentiated among the groups. To determine the groups for which the predictors of aspiration were the most evident, we used Fisher\'s exact test. In that analysis, the groups were matched for predictors of aspiration-multiple swallows: ASHA1 vs. ASHA2 (p = 0.559); ASHA1 vs. ASHA3 (p = 0.011); and ASHA2 vs. ASHA3 (p = 0.030); abnormal cervical auscultation findings: ASHA1 vs. ASHA2 (p = 0.001); ASHA1 vs. ASHA3 (p \< 0.001); and ASHA2 vs. ASHA3 (p = 0.004); wet voice: ASHA1 vs. ASHA2 (p = 0.236); ASHA1 vs. ASHA3 (p = 0.002); and ASHA2 vs. ASHA3 (p = 0.031); cough after swallowing: ASHA1 vs. ASHA2 (p = 0.072); ASHA1 vs. ASHA3 (p \< 0.001); and ASHA2 vs. ASHA3 (p \< 0.001); and choking: ASHA1 vs. ASHA2 (p = 0.630); ASHA1 vs. ASHA3 (p = 0.002); and ASHA2 vs. ASHA3 (p = 0.004).

[Tables 3](#t03){ref-type="table"} and [4](#t04){ref-type="table"} show the results of the comparison of patient severity of illness (SOFA) among levels of swallowing function at the time of speech pathology assessment.

Table 3.Comparison of patient severity of illness among levels of swallowing function.**Level of wallowing functionMedianIQRp**ASHA15.03.75-8.000.001ASHA25.03.00-7.00ASHA33.02.00-5.00[^4]

Table 4.Multiple comparisons of patient severity of illness among levels of swallowing function.**Comparisonp**ASHA1 vs. ASHA2\> 0.999ASHA1 vs. ASHA30.003ASHA2 vs. ASHA30.005[^5]

The results of the two analyses indicate that poor swallowing function translates to greater patient severity of illness. It can also be seen that the ASHA1 group (patients who cannot tolerate oral feeding) and the ASHA2 group (patients who require maximum to moderate diet restriction) did not differ regarding patient severity of illness (SOFA score).

To establish which indicators of patient severity of illness could have an impact on swallowing, we sought to determine whether indicators of functioning of the respiratory, cardiovascular, and central nervous systems (SOFA score) correlate with level of swallowing function at the time of speech pathology assessment ([Table 5](#t05){ref-type="table"}). The results indicated that only changes in the central nervous system correlated with changes in swallowing function, indicating that poor swallowing function translates to central nervous system impairment. In an analysis solely of the indicator of functioning of the central nervous system, Dunn\'s test indicated that the group with the poorest swallowing function differed from the others: ASHA1 vs. ASHA2 (p = 0.018); ASHA1 vs. ASHA3 (p \< 0.001); and ASHA2 vs. ASHA3 (p = 0.101).

Table 5.Comparison of the severity of involvement of the respiratory, cardiovascular, and central nervous systems among levels of swallowing function.**SOFA scoreGrouppASHA1ASHA2ASHA3(n = 38)(n = 61)(n = 51)Respiratory**0813140.4361141315291873714134032**Cardiovascular**02849470.5071231211135714211**CNS**01540430.00111818834204310[^6]

DISCUSSION
==========

This study presents the characteristics of the risk of bronchial aspiration in the largest sample of patients after prolonged OTI in Brazil. Establishing priority indicators for post-extubation speech pathology care is essential to reducing hospital costs, optimizing bedside speech pathology assessment, and promoting safe and speedy resumption of oral feeding.

The literature indicates that the impact of age on the occurrence of dysphagia after prolonged OTI is similar in young adults and in the elderly^(^ [@B24] ^,^ [@B25] ^)^; both groups seem to differ only in dysphagia resolution, the elderly having a trend toward delayed resumption of oral feeding.^(^ [@B02] ^,^ [@B18] ^,^ [@B26] ^)^ In contrast, the present study showed that predictors of bronchial aspiration were more common in individuals 55 years of age or older.

A previous study reported the impact of aging on the swallowing function, indicating that healthy elderly individuals present with vallecular residuals (laryngeal retention) and that such individuals are usually unaware of retained food in the pharynx.^(^ [@B27] ^)^ Although pharyngeal clearing is nearly complete in young, asymptomatic individuals, the same is not true for healthy elderly individuals.^(^ [@B27] ^)^ The mechanisms responsible for the development of pharyngeal retention have yet to be fully determined. According to the literature,^(^ [@B28] ^,^ [@B29] ^)^ age-related physiological changes-reduced amplitude of pharyngeal contractions, pharyngeal shortening, reduced tongue propulsion/strength, and reduced soft palate strength, all of which hinder the displacement of the food bolus-may be involved in the impairment of the swallowing process. Those factors could also explain the higher frequency of occurrence of cough and abnormal auscultation findings after swallowing, observed in the present study, in the critically ill patients 55 years of age or older.

The association between duration of orotracheal intubation and dysphagia severity is well documented in the literature.^(^ [@B01] ^,^ [@B12] ^,^ [@B19] ^,^ [@B30] ^,^ [@B31] ^)^ This association can be explained by the impact of the tube remaining in the oral cavity, pharynx, and larynx. It is known that chemoreceptors and/or mechanoreceptors, located in the pharyngeal and laryngeal mucosa and involved in the swallowing reflex, can undergo changes due to the presence of an orotracheal tube.^(^ [@B03] ^)^ Laryngeal sensory impairment, identified by the absence of cough or of any other clinical sign suggestive of aspiration, has been observed in patients during the ingestion of liquids, immediately after extubation and within 4 h after extubation.^(^ [@B32] ^,^ [@B33] ^)^ The results of the present study suggest that predictors of aspiration are more common in individuals who remain intubated for 6 days or more.

The present study identified abnormal cervical auscultation findings as a possible predictor of bronchial aspiration. The sounds associated with healthy and pathological swallowing have been identified with the aid of accelerometers and microphones, for analysis of acoustic characteristics^(^ [@B34] ^,^ [@B35] ^)^ and determination of the characteristic sounds of swallowing.^(^ [@B35] ^-^ [@B37] ^)^ The results regarding the accuracy of the method vary considerably in terms of reliability and validity in comparison with those of imaging.^(^ [@B38] ^)^ In contrast, it should be taken into consideration that the very interpretation of videofluoroscopy images and results also varies in terms of reliability and reproducibility.^(^ [@B39] ^,^ [@B40] ^)^ Regardless of the method adopted to assess swallowing, there is a consensus that specific training in its use is indispensable.

Data analysis indicated that, in the present study, critically ill patients who underwent prolonged OTI and had poorer swallowing function had greater overall severity of illness, changes in the central nervous system being the factor with the greatest impact on this difference. As shown in the introduction, the results of the studies that correlated patient severity of illness (SOFA score) with dysphagia severity did not achieve significance.^(^ [@B19] ^,^ [@B20] ^)^ However, the item regarding neurological system impairment was not included in the analyses of those studies. The literature has identified that a decreased level of consciousness has impacts on the swallowing mechanism and can lead to aspiration.^(^ [@B02] ^,^ [@B05] ^,^ [@B31] ^)^

Finally, the limitations of the present study should be acknowledged. First, the study sample consisted of patients from a single institution, and, therefore, the results might have some bias resulting from the therapeutic approaches adopted in the specific protocols. Second, the type of assessment proposed for identifying predictors of bronchial aspiration was based solely on an observational clinical protocol. Determination of the actual occurrence of bronchial aspiration, on the basis of the signs evaluated, was not objectively confirmed by imaging. It is of note that the present study did not exclude full speech pathology assessments, including imaging.

The results of the present study suggest that critically ill patients 55 years of age or older who undergo prolonged OTI (≥ 6 days), have a SOFA score ≥ 5, have a Glasgow Coma Scale score ≤ 14, and present with abnormal cervical auscultation findings or cough after swallowing (5 mL water swallow test at the bedside) should be prioritized for a full speech pathology assessment and, if necessary, referred for imaging confirmation.

Financial support: None.

Study carried out in the Divisão de Fonoaudiologia, Instituto Central, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.

[^1]: MAP: mean arterial pressure; and SNC central nervous system. ^a^With ventilatory support. ^b^Adrenergic agents (µg/kg body weight/min) were administered for at least 1 h.

[^2]: ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS. \*ANOVA.

[^3]: ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS. ^a^Food or liquid escaping from the mouth or nose. \*Chi-square test.

[^4]: IQR: interquartile range; ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS. \*Kruskal-Wallis test.

[^5]: ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS.\*Dunn\'s test.

[^6]: SOFA: Sequential Organ Failure Assessment; ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS; and CNS: central nervous system. \*Chi-square test.
